NeurATRIS has high-tech platforms and complementary models (cells, animals) to screen, characterise, evaluate and validate your most promising developments up to the patient (Phase II).
PLATFORMS
NEUROIMAGING: PET, MRI, PET-CT, PET-MRI, SPECT
COGNITION AND BEHAVIOR: Memory, language, motivation, movement, muscular strength
ELECTROPHYSIOLOGY: patch recording, MEG and EEG, recordings from cell cultures, brain slices
COMPLEMENTARY EXPERTISE: ex vivo imaging, HTS, applied immunology, high-throughput real time PCR, biochemistry, proteomics, pharmacokinetics, etc.
BIOSAFETY: BSL1, 2, 3 for neurosurgery, imaging, histopathology, behavior, etc.
NeurATRIS thus gives you access to a powerful range of expertise and equipment covering the drug and biomarker discovery value chain through a one-stop shop.
For each of these pathologies, NeurATRIS offers you an unequalled combination of high-level platforms and multidisciplinary expertise.
In order to offer you the most appropriate models and tools for your needs and the targets of your therapeutic strategies, the technical, scientific and clinical experts at NeurATRIS remain your key contacts for finalising together and made-to-measure your projects.